Literature DB >> 21097396

[Construction of let-7a expression plasmid and its inhibitory effect on k-Ras protein in A549 lung cancer cells].

Xiao-yan He1, Jun-xia Chen, Xi Ou-Yang, Zheng Zhang, Hui-min Peng.   

Abstract

OBJECTIVE: To elucidate the role of let-7a-mediated gene regulation in the pathogenesis of lung cancer.
METHODS: Two template DNA sequences were designed based on hsa-let-7a sequence in miRBase database. The let-7a expression construct and a control plasmid, namely pGenesil-let-7a and pGenesil-control, respectively, were generated by cloning the annealed oligonucleotides into pGenesil-1 and then transfected into A549 cells, which were selected by G418 to establish the lung cancer cell lines stably expressing let-7a-GFP and control-GFP. The living cells were counted by MTT assay and cell growth curves were drawn to analyze the cell proliferation. The k-Ras mRNA level was assessed by semi-quantitative RT-PCR, and the expression of k-Ras protein was determined by Western blotting and immunocytochemistry.
RESULTS: The recombinant vectors were verified by sequencing. The cell growth curves indicated that the proliferation of the cells transfected with pGenesil- let-7a were inhibited significantly compared with that of cells transfected with pGenesil-control and A549 cells. Semi- quantitative RT-PCR analysis showed that the levels of k-Ras mRNA almost remained unchanged in cells with or without the treatments. Western blotting and immunocytochemistry demonstrated a significant decrease of k-Ras protein levels in cells transfected with pGenesil-let-7a, but not in cells transfected with pGenesil-control, when compared to A549 cells.
CONCLUSION: let-7a over-expression represses the expression of k-Ras protein and significantly inhibits the growth of lung cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21097396

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  5 in total

1.  The role of JNK phosphorylation as a molecular target to enhance adenovirus replication, oncolysis and cancer therapeutic efficacy.

Authors:  Stephen L Wechman; Xiao-Mei Rao; Jorge G Gomez-Gutierrez; Heshan Sam Zhou; Kelly M McMasters
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

2.  MicroRNAs and cancer: Key paradigms in molecular therapy.

Authors:  Weige Tan; Bodu Liu; Shaohua Qu; Gehao Liang; Wei Luo; Chang Gong
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

3.  Effect of Combined Perftoran and Indocyanine Green-Photodynamic Therapy on HypoxamiRs and OncomiRs in Lung Cancer Cells.

Authors:  Amira M Gamal-Eldeen; Amani A Alrehaili; Afaf Alharthi; Bassem M Raafat
Journal:  Front Pharmacol       Date:  2022-03-16       Impact factor: 5.810

4.  Naringenin Ameliorated Kidney Injury through Let-7a/TGFBR1 Signaling in Diabetic Nephropathy.

Authors:  Ning Yan; Li Wen; Rui Peng; Hongmei Li; Handeng Liu; Huimin Peng; Yan Sun; Tianhui Wu; Lei Chen; Qingrui Duan; Yixuan Sun; Qin Zhou; Lijiang Wei; Zheng Zhang
Journal:  J Diabetes Res       Date:  2016-06-30       Impact factor: 4.011

Review 5.  Development of MicroRNAs as Potential Therapeutics against Cancer.

Authors:  Noraini Abd-Aziz; Nur Izyani Kamaruzman; Chit Laa Poh
Journal:  J Oncol       Date:  2020-07-15       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.